Omeros OMER
NASDAQ OMER
$19.13 +0.02 (+0.10%)
As of: Sep 4, 2026 · 3:20 PM EDT

Omeros (OMER) Cash & Equivalents (2010 - 2026)

Omeros (OMER) posted Cash & Equivalents of $1.9 million for Q1 2026, down 80.27% sequentially from $9.7 million in Q4 2025, and down 55.27% YoY from $4.3 million in Q1 2025.

Analysis

Omeros (OMER) Cash & Equivalents (2010 - 2026) Analysis & Trends

Omeros has reported Cash & Equivalents for 17 years, with the latest figure at $1.9 million in Q1 2026.

  • Quarterly Cash & Equivalents fell 55.27% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 55.27% YoY) and the FY2025 annual result came in at $9.7 million, up 184.12% from the prior year.
  • Cash & Equivalents slipped to $1.9 million in Q1 2026 per OMER's latest filing, from $9.7 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $310.3 million in Q3 2023 and troughed at $1.5 million in Q3 2024.
  • A 5-year average of $48.6 million and a median of $9.0 million in 2022 frame the typical range for Cash & Equivalents.
  • The widest YoY moves for Cash & Equivalents: up 5960.53% in 2024, down 99.51% in 2024.
  • Over 5 years, Cash & Equivalents stood at $11.0 million in 2022, then slumped by 35.46% to $7.1 million in 2023, then sank by 52.15% to $3.4 million in 2024, then jumped by 184.12% to $9.7 million in 2025, then tumbled by 80.27% to $1.9 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $1.9 million, $9.7 million, and $36.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 3.58 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 815.44 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 811.99 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 544.80 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 1.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.99 Mn
Mar 31, 2026 1.91 Mn
Dec 31, 2025 9.66 Mn
Sep 30, 2025 36.10 Mn
Jun 30, 2025 28.70 Mn
Mar 31, 2025 52.40 Mn
Dec 31, 2024 3.40 Mn
Sep 30, 2024 123.20 Mn
Jun 30, 2024 158.90 Mn
Mar 31, 2024 230.30 Mn
Dec 31, 2023 7.11 Mn
Sep 30, 2023 310.30 Mn
Jun 30, 2023 341.30 Mn
Mar 31, 2023 371.40 Mn
Dec 31, 2022 11.01 Mn
Sep 30, 2022 221.00 Mn
Jun 30, 2022 122.60 Mn
Mar 31, 2022 142.20 Mn
Dec 31, 2021 100.81 Mn
Sep 30, 2021 50.40 Mn